Authors submitting to this journal can opt to use a new service that will make it easier to share research data.
Find out more here.
Collection: Hepatitis C
The 2020 Nobel Prize for Physiology or Medicine was awarded to Harvey J. Alter, Michael Houghton and Charles M. Rice for their discovery of Hepatitis C virus. In celebration of what they started and showcasing areas of research that have since emerged, we here present a collection of articles from the BMC Biology, BMC Medicine, Genome Medicine and the BMC Series Journals on biology, diagnosis and treatment and wider public health and medical outcomes of the Hepatitis C virus and its infection.
Spotlight On
High resolution biology
High-resolution imaging and genomic technologies are changing the way we view the environment, cells, chromosomes and molecules. Here we share recent highlights from the BMC Series journals.
Featured articles
Adverse drug reactions in children
Can we use the Adverse Drug Event Report database for drug safety surveillance in Children? This study on the Japanese database evaluates.
Can Statin combat antipsychotics-induced weight gain?
In this study in young rats, the authors test the efficacy of statin interventions and particularly, Simvastatin, in reversing second generation antipsychotics-induced dyslipidemia.
Articles
-
-
Beneficial effects of Cyclosporine A in combination with Nortriptyline on germ cell-specific apoptosis, oxidative stress and epididymal sperm qualities following testicular ischemia/reperfusion in rats: a comparative study
-
Pharmacological evaluation of newly synthesized organotin IV complex for antiulcer potential
-
A randomized, double-blind, phase III, non-inferiority clinical trial comparing the efficacy and safety of TA4415V (a proposed Trastuzumab biosimilar) and Herceptin (Trastuzumab reference product) in HER2-positive early-stage breast Cancer patients
-
Cytotoxic and apoptotic potential of gemini-chrysophanol nanoparticles against human colorectal cancer HCT-116 cell lines
-
A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic medicines, using Ireland as a case study
-
Deflazacort: therapeutic index, relative potency and equivalent doses versus other corticosteroids
-
A case report of zinc phosphide poisoning: complicated by acute renal failure and tubulo interstitial nephritis
-
Rosacea-like facial rash related to metformin administration in a young woman
-
Toxicological evaluation of therapeutic and supra-therapeutic doses of Cellgevity® on reproductive function and biochemical indices in Wistar rats
Aims and scope
BMC Pharmacology and Toxicology is an open access, peer-reviewed journal that considers articles on all aspects of chemically defined therapeutic and toxic agents. The journal welcomes submissions from all fields of experimental and clinical pharmacology including clinical trials and toxicology.
Data support service
BMC Series Blog
-
Highlights of the BMC Series – June 2022
22 July 2022
-
-
Highlights of the BMC Series – May 2022
21 June 2022
Latest Tweets
View Twitter timeline
Your browser needs to have JavaScript enabled to view this timeline
Annual Journal Metrics
-
Citation Impact
2.605 - 2-year Impact Factor (2021)
2.943 - 5-year Impact Factor (2021)
0.953 - SNIP (Source Normalized Impact per Paper)
0.497 - SJR (SCImago Journal Rank)Speed
42 days to first decision for all manuscripts (Median)
172 days to first decision for reviewed manuscripts only (Median)Usage
588,461 Downloads (2021)
402 Altmetric mentions (2021)
Peer-review Terminology
-
The following summary describes the peer review process for this journal:
Identity transparency: Single anonymized
Reviewer interacts with: Editor
Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication